Stoke Therapeutics STOK
NASDAQ STOK
$26.33 +0.45 (+1.74%)
As of: Sep 30, 2026 · 2:31 PM EDT

Stoke Therapeutics (STOK) Revenue (2022 - 2026)

Updated

Stoke Therapeutics (STOK) recorded Revenue of $9.33 million in Q2 2026, down 32.5% from $13.82 million a year earlier but up 49.7% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Revenue (2022 - 2026) Analysis & Trends

On a TTM basis, Stoke Therapeutics' Revenue came in at $27.59 million as of Jun 30, 2026, down 86.2% year-over-year; for FY2025, it was $184.42 million, up 404.5% from FY2024.

  • Annual Revenue has a three-year compound annual growth rate of 145.9% (FY2022 to FY2025).
  • Across earlier years, Revenue came in at $36.56 million in FY2024 (+316.3%), $8.78 million in FY2023 (-29.2%) and $12.41 million in FY2022.
  • Quarterly Revenue has ranged from $1.4 million in Q4 2025 to $158.57 million in Q1 2025 over the past five years.
  • On a year-over-year basis, Revenue has declined for three consecutive quarters, with growth averaging 119.4% over the last seven quarters.
  • Peak year-over-year performance for Revenue in the last five years was growth of 707.1% in Q4 2024, against a decline of 96.1% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.23 million (Q1 2026), $1.4 million (Q4 2025) and $10.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Stoke Therapeutics 1.61 Bn 445.64 Mn - 9.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.33 Mn
Mar 31, 2026 6.23 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 10.63 Mn
Jun 30, 2025 13.82 Mn
Mar 31, 2025 158.57 Mn
Dec 31, 2024 22.61 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 4.83 Mn
Mar 31, 2024 4.22 Mn
Dec 31, 2023 2.80 Mn
Sep 30, 2023 3.31 Mn
Jun 30, 2023 2.48 Mn
Mar 31, 2023 5.15 Mn
Dec 31, 2022 3.27 Mn
Sep 30, 2022 2.91 Mn
Jun 30, 2022 3.23 Mn
Mar 31, 2022 3.00 Mn
API Access

Stoke Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=STOK&period=max&api_key=YOUR_API_KEY